FDA,
USP, national institutes for Food and Drug Control and leading pharmaceutical
companies from home and abroad were invited to give presentations. More than
180 generic drug makers attended the summit. It was an unprecedentedly grand
occasion and won a favorable reception.
In
November 2012, over 200 decision makers from the government, generics companies
and original medicine companies gathered for the 2nd Nextgen China, which was
held in Beijing. They discussed the latest regulations, market conditions and
technology and gave high evaluations of this summit.
In
March 2013, the 3rd Nextgen China ended successfully at the Shanghai Crowne
Plaza Century. During the two days of this summit, famous experts and
representatives from pharmaceutical companies were invited to make speeches and
over 100 experts and guests from the generic industry took part in active
discussions. They gave an overview of the latest market situation and provided
more cooperation opportunities.
Based
on the great success of the 3 former sessions of NEXTGEN conferences, CPhI will
conduct The 4th NEXTGEN China 2014 Conference from March 27-28 2014 in
Shanghai. CPhI will gather all the essence and global resources into this
conference to bring further information and experience sharing. This summit
will provide a special session for Generics Consistency Evaluation, to
summarize the evaluation work from 2013 and explore programs for 2014. Speakers
at this summit are from the two aspects of the pharmaceutical industry: Regulatory
Updates and Technology & Market. In the area of regulatory
updates, Mr. Wang, a researcher at the National Drug Policy & Economic
Research Center (NDPE), will deliver a speech, entitled "Generics Quality
Improvement In China". In the area of technology and market, national
"one thousand program" distinguished expert Jeannie Zhang will give a
speech on the research of APIs and technology development. Meanwhile, the
committee will provide two panel discussions. On day one, the president of
RDPAC, Joseph Cho, will moderate a discussion on the specific practice of
generics consistency evaluation. On day two, the vice president of Huahai US
will discuss the topic of how to establish strategic partnerships and
breakthrough technique difficulties to improve generics market access.
For
more details and to learn more about the agenda and speakers for Nextgen China
2014, please click http://www.nextgen-china.com/Download.aspx?id=6&lang=en-us&source=news0312.
Operated
by CPhI Global Conferences, Nextgen China 2014 involves first-class drug companies as
well as famous experts and scholars from home and abroad, aiming to help you
learn the latest laws and regulations, improve the quality of generic drug
production, and seize chances to get ahead in the market.
Contact Information:
Sally
Chen
Phone Number: +86-21-61573930
Email: askconference@ubm.com
Website: http://www.nextgen-china.com/
Nenhum comentário:
Postar um comentário